COVID-19 global clinical growth rate is about 17 times

The koNECT counted, 36% increase in plasma utilization

The global clinical trial of 'COVID-19' is steadily increasing.

 

The increase rate is close to 17 times from March to the present.

 

15 cases have been approved in Korea, and research is actively underway, and as a whole, clinical trials of plasma devices using plasma of cured patients have surged 36 times.

 

According to the trend of domestic and foreign clinical trials for the development of vaccines and treatments for COVID-19 vaccines updated by the Korea National Enterprise for Clinical Trials (Chairman Byung-Joon Bae) on the 23rd, there were 941 Drug Interventional Clinical Trials in COVID-19 newly registered at the National Institutes of Health (NIH) ClinicalTrials.gov on the 22nd.

 

As of March 11, the total number of clinical trials increased 16.8 times from 56 cases to 941 cases.

 

In particular, the number of sponsor-investigator trials increased by 19.1 times from 32 to 612, and it was analyzed that the sponsor-investigator trials aimed at the public interest in responding to the national public health crisis are driving clinical research.

 

905 were clinical trials related to treatment and 36 were clinical trials related to vaccines of the 941 clinical trials.

 

Among clinical trials related to treatment, 591 cases of researcher's clinical trials, 297 of clinical trials of pharmaceutical companies, NIH and U.S.

 

Fed-sponsored clinical trials were 17 cases, and the proportion of sponsor-investigator trials was 65.3%.

 

In particular, clinical trials for blood plasma treatments using plasma of cured patients surged 36 times from 3 cases to 108 cases as of March 11th.

 

COVID-19 related clinical trial plans approved by the MFDS were 15 cases on the 22nd of this month.

 

13 clinical trials related to treatments and 2 clinical trials related to vaccines were conducted, and 7 clinical trials (46.7%) were reported to be in progress.

 

Meanwhile, information on the current status of clinical trials related to COVID-19 can be viewed and downloaded from the Korean Clinical Trial Portal (K-CLIC).